Amidaron

To prevent recurrences of:

• ventricular tachycardia, which is life-threatening; treatment should be initiated in a hospital setting with constant monitoring of the patient’s condition;
• symptomatic ventricular tachycardia (documented), which leads to disability;
• supraventricular tachycardia (documented), which requires treatment, and in cases where other medicinal products do not have a therapeutic effect or are contraindicated;
• ventricular fibrillation.

For the treatment of supraventricular tachycardia: slowing or reducing atrial fibrillation or flutter.

Coronary heart disease and/or left ventricular dysfunction (see section “Pharmacodynamics”).